LDS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $5M
- Transactions
- 421
- Companies
- 40
- Average per transaction
- $11,813
Who reported the payments
| Olympus Corporation | $1,552,155 |
| Hoffmann-la Roche Limited | $836,422 |
| Genentech, Inc. | $342,962 |
| Roche Products Limited | $305,717 |
| Gilead | $296,136 |
| BD | $290,500 |
| AbbVie | $247,116 |
| Ethicon Endo-surgery Inc. | $150,000 |
| Pharmacyclics LLC, An Abbvie Company | $124,640 |
| Genmab A/s | $122,558 |
| Syndax Pharmaceuticals, Inc. | $112,218 |
| E.r. Squibb & Sons, L.L.C. | $102,004 |
| Novartis | $56,690 |
| National Marrow Donor Program | $53,125 |
| Merck | $50,021 |
| Astellas Pharma Global Development | $45,476 |
| Dexcom, Inc. | $42,613 |
| EMD Serono, Inc. | $35,500 |
| Actelion Pharmaceuticals US, Inc. | $33,173 |
| Medical Device Business Services, Inc. | $19,604 |
| Baxter Healthcare | $16,360 |
| Regeneron | $15,703 |
| Sumitomo Pharma America, Inc. | $15,232 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14,300 |
| Incyte Corporation | $14,015 |
| Array Biopharma Inc | $13,000 |
| Zimmer Biomet | $11,286 |
| Johnson & Johnson | $8,500 |
| Bayer | $8,250 |
| Olympus America Inc. | $7,365 |
| Boston Scientific | $6,529 |
| Alnylam Pharmaceuticals Inc. | $5,000 |
| Amgen | $4,996 |
| Edwards Lifesciences | $4,500 |
| Sterilmed, Inc. | $3,569 |
| Genentech USA, Inc. | $2,000 |
| Sanofi | $1,000 |
| AstraZeneca | $750 |
| Jazz Pharmaceuticals Inc. | $750 |
| Sanofi Pasteur Inc. | $750 |